SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on DexCom at the following upcoming investor conference:
- Kevin Sayer, President and Chief Executive Officer, will present an update on the company at the J.P. Morgan 36th Annual Healthcare Conference in San Francisco, California, on Tuesday, January 9, 2018, at 11:00 a.m. (PST). The presentation, which will occur live at the Westin St. Francis Hotel, will be concurrently webcast.
The link to the webcast will be available on the DexCom website at www.dexcom.com by navigating to "Our Company," then "Investor Relations," and finally "Events and Webcasts" and will be archived there for future reference.
About DexCom, Inc.
DexCom, Inc., headquartered in San Diego, California, is developing and marketing continuous glucose monitoring systems for ambulatory use by patients and by healthcare providers in the hospital.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171212005028/en/
DexCom, Inc.
Steven R. Pacelli
Executive Vice President, Strategy and Corporate Development
(858) 200-0200
Source: DexCom, Inc.
News Provided by Acquire Media